| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 7 securities · passive | ||||||
|
Nuvectis Pharma, Inc.
13G
NVCT · 67080T108
|
5.1% |
8/6/2026
Event 8/4/2026
|
||||
| Soleus Private Equity Fund III, L.P. | 0.5% | |||||
| Soleus Private Equity GP III, LLC | 0.5% | |||||
| Soleus PE GP III, LLC | 0.5% | |||||
| Soleus Capital Master Fund, L.P. | 4.6% | |||||
| Soleus Capital, LLC | 4.6% | |||||
| Soleus Capital Group, LLC | 4.6% | |||||
| Soleus Capital Management, L.P. | 5.1% | |||||
| Soleus GP, LLC | 5.1% | |||||
| Levy Guy | 5.1% | |||||
|
Prelude Therapeutics Inc
13G
PRLD · 74065P101
|
5.2% |
7/8/2026
Event 4/21/2026
|
||||
| Soleus Private Equity Fund III, L.P. | 1.0% | |||||
| Soleus Private Equity GP III, LLC | 1.0% | |||||
| Soleus PE GP III, LLC | 1.0% | |||||
| Soleus Capital Master Fund, L.P. | 4.2% | |||||
| Soleus Capital, LLC | 4.2% | |||||
| Soleus Capital Group, LLC | 4.2% | |||||
| Soleus Capital Management, L.P. | 5.2% | |||||
| Soleus GP, LLC | 5.2% | |||||
| Levy Guy | 5.2% | |||||
|
CalciMedica, Inc.
13G/A
CALC · 38942Q202
|
2.4% |
5/8/2026
Event 3/31/2026
|
||||
| Soleus Private Equity Fund III, L.P. | 1.2% | |||||
| Soleus Private Equity GP III, LLC | 1.2% | |||||
| Soleus PE GP III, LLC | 1.2% | |||||
| Soleus Capital Master Fund, L.P. | 1.2% | |||||
| Soleus Capital, LLC | 1.2% | |||||
| Soleus Capital Group, LLC | 1.2% | |||||
| Soleus Capital Management, L.P. | 2.4% | |||||
| Soleus GP, LLC | 2.4% | |||||
| Guy Levy | 2.4% | |||||
|
Aprea Therapeutics, Inc.
13G
APRE · 03836J102
|
10.0%
Checked 5% or less
|
4/1/2026
Event 4/1/2026
|
||||
| Soleus Private Equity Fund III, L.P. | 10.0% | |||||
| Soleus Private Equity GP III, LLC | 10.0% | |||||
| Soleus PE GP III, LLC | 10.0% | |||||
| Soleus Capital Master Fund, L.P. | 10.0% | |||||
| Soleus Capital, LLC | 10.0% | |||||
| Soleus Capital Group, LLC | 10.0% | |||||
| Soleus Capital Management, L.P. | 10.0% | |||||
| Soleus GP, LLC | 10.0% | |||||
| Guy Levy | 10.0% | |||||
|
Invivyd, Inc.
13G/A
IVVD · 00534A102
|
2.8% |
2/12/2026
Event 12/31/2025
|
||||
| Soleus Private Equity Fund III, L.P. | 0.6% | |||||
| Soleus Private Equity GP III, LLC | 0.6% | |||||
| Soleus PE GP III, LLC | 0.6% | |||||
| Soleus Capital Master Fund, L.P. | 2.2% | |||||
| Soleus Capital, LLC | 2.2% | |||||
| Soleus Capital Group, LLC | 2.2% | |||||
| Soleus Capital Management, L.P. | 2.8% | |||||
| Soleus GP, LLC | 2.8% | |||||
| Guy Levy | 2.8% | |||||
|
Immunic, Inc.
13G/A
IMUX · 4525EP101
|
1.6% |
11/7/2025
Event 9/30/2025
|
||||
| Soleus Private Equity Fund III, L.P. | 1.1% | |||||
| Soleus Private Equity GP III, LLC | 1.1% | |||||
| Soleus PE GP III, LLC | 1.1% | |||||
| Soleus Capital Master Fund, L.P. | 0.5% | |||||
| Soleus Capital, LLC | 0.5% | |||||
| Soleus Capital Group, LLC | 0.5% | |||||
| Soleus Capital Management, L.P. | 1.6% | |||||
| Soleus GP, LLC | 1.6% | |||||
| Guy Levy | 1.6% | |||||
|
Verastem, Inc.
13G/A
VSTM · 92337C203
|
1.8% |
5/2/2025
Event 3/31/2025
|
||||
| Soleus Private Equity Fund III, L.P. | 0.7% | |||||
| Soleus Private Equity GP III, LLC | 0.7% | |||||
| Soleus PE GP III, LLC | 0.7% | |||||
| Soleus Capital Master Fund, L.P. | 1.2% | |||||
| Soleus Capital, LLC | 1.2% | |||||
| Soleus Capital Group, LLC | 1.2% | |||||
| Soleus Capital Management, L.P. | 1.8% | |||||
| Soleus GP, LLC | 1.8% | |||||
| Guy Levy | 1.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.